Bio-Rad Laboratories, Inc. (NYSE:BIO.B – Get Free Report) shares gapped down before the market opened on Wednesday . The stock had previously closed at $343.85, but opened at $319.37. Bio-Rad Laboratories shares last traded at $319.37, with a volume of 256 shares trading hands.
Bio-Rad Laboratories Stock Performance
The company has a current ratio of 6.14, a quick ratio of 4.52 and a debt-to-equity ratio of 0.16. The business’s 50 day moving average is $338.71 and its two-hundred day moving average is $333.00. The company has a market cap of $8.94 billion, a PE ratio of -11.69 and a beta of 0.73.
Bio-Rad Laboratories Company Profile
Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.
See Also
- Five stocks we like better than Bio-Rad Laboratories
- How to Most Effectively Use the MarketBeat Earnings Screener
- 3 Reasons Micron Stock Is Deeply Undervalued Right Now
- The 3 Best Blue-Chip Stocks to Buy Now
- Inflation Persists, But So Do Stock Opportunities: Rally On
- Airline Stocks – Top Airline Stocks to Buy Now
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
Receive News & Ratings for Bio-Rad Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio-Rad Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
